Christopher Haqq
Hoofd Techniek/Wetenschap/O&O bij ELICIO THERAPEUTICS, INC.
Vermogen: 291 027 $ op 30-04-2024
Actieve functies van Christopher Haqq
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ELICIO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2019 | - |
Loopbaan van Christopher Haqq
Eerdere bekende functies van Christopher Haqq
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-10-2019 | 01-06-2023 |
SURROZEN, INC. | Directeur/Bestuurslid | 01-11-2020 | 01-04-2021 |
Independent Dir/Board Member | 01-11-2020 | 01-04-2021 | |
ATARA BIOTHERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2012 | 25-10-2019 |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Hoofd Techniek/Wetenschap/O&O | 29-07-2009 | 01-09-2011 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Hoofd Techniek/Wetenschap/O&O | 01-03-2007 | 13-07-2009 |
The University of California, San Francisco | Corporate Officer/Principal | - | - |
AMGEN INC. | Corporate Officer/Principal | - | - |
Opleiding van Christopher Haqq
Harvard Medical School | Doctorate Degree |
Stanford University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 11 |
Operationeel
Chief Tech/Sci/R&D Officer | 5 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 7 |
Consumer Services | 4 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
AMGEN INC. | Health Technology |
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
ELICIO THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |
Consonance-HFW Acquisition Corp.
Consonance-HFW Acquisition Corp. Financial ConglomeratesFinance Consonance-HFW Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisitions, share purchase, reorganization, or similar business combination. The company was founded by Gad Soffer and Kevin Harold Livingston on August 21, 2020 and is headquartered in Princeton, NJ. | Finance |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Christopher Haqq
- Ervaring